Dr. Eileen Connolly, who specializes in breast cancer radiation oncology, takes us through the major advancements in breast cancer radiotherapy and the exciting research and new approaches ahead.
Dr. Kathy Crew's work in breast cancer risk, prevention, and screening has been instrumental in the advancement of breast cancer research. In this Q+A, she discusses where we are in treatment, in research, and the challenges that lie ahead.
An annual tradition of the fall season is Velocity: Columbia’s Ride to End Cancer. This year, in response to COVID-19, Velocity is taking a new, personal approach called Your Velocity(link is external and opens in a new window).
Michael Shen, PhD, is a leading expert in prostate cancer and bladder cancer research. His ongoing work with three-dimensional cultures--organoids--to study prostate and bladder cancer could contribute to the development of new therapies and uncover key new insights to the molecular mechanisms responsible for tumor evolution and drug response.
A novel, emerging technique, called FLASH radiotherapy, has the potential to drastically shorten radiation treatment for cancer patients. A team of researchers at Columbia and the HICCC are dedicated to uncovering the underlying mechanisms behind this new, potentially life-changing cancer therapeutic.
Anil K. Rustgi shares his thoughts on how COVID-19 has shown that coordinating efforts across all aspects of science are vital to the success of our fight against this infectious disease.
Meet Calvin Martin, a member of the Community Advisory Board at the Herbert Irving Comprehensive Cancer Center. Calvin is a prostate cancer survivor and patient advocate who shares his own cancer story to raise awareness about the importance of routine screenings and to quell misconceptions of the disease.
